Cargando…
Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes
Most preclinical treatments for sepsis failed in clinical trials in part because the experimental models of sepsis were performed on healthy animals that do not mimic septic patients. Here, we report that experimental diabetes worsens glycemia, inflammation, and mortality in experimental sepsis. Dia...
Autores principales: | Feketeova, Eleonora, Li, Zhifeng, Joseph, Biju, Shah, Roshan, Spolarics, Zoltan, Ulloa, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945822/ https://www.ncbi.nlm.nih.gov/pubmed/29780390 http://dx.doi.org/10.3389/fimmu.2018.00943 |
Ejemplares similares
-
Glucose Activates Vagal Control of Hyperglycemia and Inflammation in Fasted Mice
por: Joseph, Biju, et al.
Publicado: (2019) -
Splenic SUMO1 controls systemic inflammation in experimental sepsis
por: Youssef, Ayman, et al.
Publicado: (2023) -
Inherent X-Linked Genetic Variability and Cellular Mosaicism Unique to Females Contribute to Sex-Related Differences in the Innate Immune Response
por: Spolarics, Zoltan, et al.
Publicado: (2017) -
Diabetes Treatment and Measures of Glycemia
por: Bloomgarden, Zachary T.
Publicado: (2009) -
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis
por: Alves, Gustavo Ferreira, et al.
Publicado: (2022)